查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829887

2025年全球腫瘤消融設備市場報告

Tumor Ablation Therapy Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤消融設備市場快速擴張，市場規模從2024年的7.2億美元成長至2025年的8.2億美元，複合年成長率達14.2%。預測期內的成長歸因於癌症發生率上升、技術進步、人口老化以及微創手術的普及。

預計未來幾年腫瘤消融器械市場將快速成長，到2029年將達到14.2億美元，複合年成長率為14.6%。預測期內的成長歸因於個人化醫療、聯合治療、人工智慧和影像引導消融、遠端醫療和遠距會診以及培訓和教育。預測期內的主要趨勢包括消融技術、影像引導、機器人和導航輔助、免疫腫瘤學整合、經皮消融以及影像引導消融的進步。

腫瘤消融器械是常用於治療腎臟、肝臟和肺部腫瘤的微創工具。這些器械利用多種技術瞄準並摧毀癌細胞，同時不傷害周圍的健康組織。

腫瘤消融設備的主要技術包括射頻消融、微波消融、冷凍消融、不可逆電穿孔消融及相關方法。不可逆電穿孔 (IRE) 是腫瘤消融治療中的一項創新技術，該技術將微秒至毫秒的電脈衝施加於不必要的組織，導致細胞膜不可逆通透化和細胞壞死。這些設備的治療可以採用外科手術、腹腔鏡介入或經皮形式，適用於治療各種類型的癌症，包括腎臟癌、肝癌、乳癌、肺癌和攝護腺癌。腫瘤消融設備的最終用戶包括醫院、腫瘤診所和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供腫瘤消融設備市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的腫瘤消融設備細分市場、市場趨勢和機遇，以及您在腫瘤消融設備行業取得成功所需的數據。本腫瘤消融設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年14.6%的成長率預測，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自加拿大和比利時等關鍵地區的微波天線陣列和熱監測感測器供應鏈中斷，從而導致微創癌症治療系統的供應減少。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

由於癌症發生率的上升，腫瘤消融設備市場正在成長。癌症是導致死亡的主要原因，約佔全球六分之一的死亡人數。腫瘤消融是一種微創手術，廣泛用於治療各種類型的腫瘤，包括肺癌、肝癌、腎臟癌和骨癌。例如，美國非營利醫療組織美國癌症協會 ( 美國 Cancer Society Inc.) 估計，2023 年美國將新增約 1,958,310 例癌症病例，高於 2022 年的 1,918,030 例。這種治療方法提供了一種有效的治療選擇，特別是對於對化療或放射線治療無反應的患者，從而支持了腫瘤消融設備市場的成長。

微創手術需求的不斷成長預計將推動腫瘤消融器械市場的發展。微創手術需要使用專門的器械和技術來最大程度地減少切口，從而減少對患者身體的傷害。腫瘤消融器械在這些手術中發揮關鍵作用，能夠有效地摧毀腫瘤，同時最大限度地減少對周圍組織的傷害。例如，美國機器人產品製造商Intuitive Surgical Inc.在2023年1月報告稱，2022年使用達文西手術系統進行的手術約有187.5萬例，較2021年的約159.4萬例成長了18%。因此，微創手術需求的不斷成長預計將推動腫瘤消融器械市場的成長。

腫瘤消融設備市場的主要企業正專注於技術進步，例如簡化操作流程、提高安全性、減少輻射暴露、縮短學習曲線以及改善患者預後。例如，2023年4月，台灣電子產品製造商仁寶電子宣布推出經皮，這是一款新型射頻消融術 (RFA) 系統，專為經皮、術中軟組織（尤其是無法切除的肝臟病變）的凝固和消融而設計。此系統利用電阻在目標組織中產生熱能，從而消融病灶。該系統有望應用於治療醫療設備，尤其是癌症治療。

領先的公司正專注於開發微創治療方法，以增強其市場競爭力。微創治療在腫瘤切除方面非常有效，可以在實現精準治療的同時最大限度地減少對周圍組織的破壞。例如，美國弗朗西斯醫療公司（Francis Medical）是一家為前列腺癌、腎臟癌和膀胱癌提供微創治療解決方案的公司，其微創水蒸氣消融療法Vanquish於2023年8月獲得美國食品藥物管理局（FDA）頒發的突破性設備認證。該認證旨在加快該設備的開發和監管評估，確保其能夠快速應用於患者。 Vanquish系統利用無菌水的熱能，透過簡單的經尿道手術對癌組織進行精準治療，從而最大限度地降低前列腺癌替代療法相關的嚴重副作用風險。

2022年8月，總部位於加拿大的泌尿系統癌症治療公司Imagin Medical以250萬美元的價格從TROD Medical NV收購了用於前列腺癌的enCAGE線圈精準消融系統。此次收購鞏固了Imagin Medical作為泌尿系統腫瘤治療公司的地位，並擴大了其在前列腺癌領域的產品組合。 TROD Medical NV是一家總部位於比利時的醫療設備公司。

腫瘤消融設備市場的主要公司包括 Galil Medical Inc.、Misonix Inc.、HealthTronics Inc.、AngioDynamics Inc.、Boston Scientific Corporation、Medtronic PLC、EDAP TMS SA、NeuWave Medical Inc.、BVM Medical Limited、Erbe Elektromedizin GmbH、AtriCure Olympus Corporation過程. 、Stryker Corporation、Merit Medical Systems Inc.、Insightec Ltd.、 Terumo Corporation、Smith & Nephew PLC、Monteris Medical Corporation、IceCure Medical Ltd.、Profound Medical Inc.、Alpinion Medical Systems Co.Ltd.、Sonacare Medical、Hologic Inc.、Endocare Inc.、Integraia Corporation Corporation。

2024年，腫瘤消融設備市場最大的地區是北美。亞太地區是腫瘤消融設備市場的第二大地區。腫瘤消融設備市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美、中東和非洲。

腫瘤消融設備市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。

腫瘤消融器械市場涵蓋用於腫瘤切除治療的射頻消融術、微波消融、冷凍消融和不可逆電穿孔消融器械的銷售。該市場中的商品價值為出廠價，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤消融設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球腫瘤消融設備市場：成長率分析
  • 全球腫瘤消融設備市場表現：規模與成長，2019-2024
  • 全球腫瘤消融設備市場預測：規模與成長，2024-2029年，2034年
  • 全球腫瘤消融設備：總目標市場（TAM）

第6章 市場細分

  • 全球腫瘤消融設備市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 射頻消融
  • 微波消融
  • 冷凍療法
  • 不可逆電穿孔消融
  • 其他技術
  • 全球腫瘤消融設備市場按治療類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 外科手術
  • 腹腔鏡
  • 經皮
  • 全球腫瘤消融設備市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 腎癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 其他用途
  • 全球腫瘤消融設備市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 腫瘤診所
  • 其他最終用戶
  • 全球腫瘤消融設備市場：射頻消融術(RFA) 細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單極射頻消融裝置
  • 雙極射頻消融裝置
  • 全球腫瘤消融設備市場：微波消融設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 高頻微波設備
  • 低頻微波設備
  • 全球腫瘤消融設備市場：依冷凍療法細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 基於液態氮的裝置
  • 基於氬氣的設備
  • 全球腫瘤消融設備市場：不可逆電穿孔消融 (IRE) 細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 奈米刀消融系統
  • 高壓脈衝發生器
  • 全球腫瘤消融設備市場：依技術（其他）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 雷射消熔裝置
  • 超音波導引高強度聚焦超音波（HIFU）
  • 化學消融技術

第7章 區域和國家分析

  • 全球腫瘤消融設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤消融設備市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 腫瘤消融設備市場：競爭格局
  • 腫瘤消融設備市場：公司簡介
    • Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Medtronic plc
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • BVM Medical Limited
  • Erbe Elektromedizin GmbH
  • AtriCure Inc.
  • Theraclion
  • INTIO Inc.
  • BIOTRONIK SE & Co. KG
  • Olympus Corporation
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Insightec Ltd.
  • Terumo Corporation
  • Smith & Nephew plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年腫瘤消融設備市場：提供新機會的國家
  • 2029年腫瘤消融設備市場：細分市場帶來新機會
  • 2029年腫瘤消融設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32827u

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.72 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.

The forecast of 14.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microwave antenna arrays and thermal monitoring sensors, sourced from key regions such as Canada and Belgium, could lead to reduced availability of minimally invasive cancer treatment systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

The rising demand for minimally invasive procedures is expected to propel the tumor ablation therapy devices market. Minimally invasive procedures involve specialized instruments and technology to minimize incisions, leading to less disruption to the patient's body. Tumor ablation therapy devices play a crucial role in these procedures by effectively destroying tumors while minimizing damage to surrounding tissues. For instance, in January 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, marking an 18% increase from the roughly 1,594,000 procedures conducted in 2021. Therefore, the growing demand for minimally invasive procedures is expected to drive the tumor ablation therapy devices market's growth.

Major companies in the tumor ablation therapy devices market are focusing on technological advancements to improve procedure efficiency, safety, reduce radiation exposure, shorten learning curves, and enhance patient outcomes. For instance, Compal Electronics, a Taiwan-based electronics manufacturing company, introduced AblatePal in April 2023, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, particularly non-resectable liver lesions. It employs electrical resistance to generate heat energy in the targeted tissue, resulting in its eradication. This system has applications in therapeutic medical devices, especially for cancer treatment.

Major companies are committed to developing minimally invasive therapies to gain a competitive edge in the market. Minimally invasive therapy is highly effective for tumor ablation, providing precise treatment with minimal disruption to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation aims to expedite the device's development and regulatory evaluation, potentially ensuring quicker patient access. The Vanquish system employs sterile water's thermal energy for precise cancer tissue treatment through a straightforward transurethral procedure, minimizing the risk of severe side effects associated with alternative prostate cancer therapies.

In August 2022, Imagin Medical, a Canada-based urologic oncology company, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from TROD Medical NV for $2.5 million. This acquisition strengthens Imagin's position as a urologic oncology company and broadens its portfolio in the field of prostate cancer. TROD Medical NV is a Belgium-based medical device company.

Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic PLC, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew PLC, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
  • 2) By Treatment: Surgical; Laparoscopic; Percutaneous
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Oncology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
  • 2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
  • 3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
  • 4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
  • 5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
  • Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation; Medtronic plc; EDAP TMS S.A.; NeuWave Medical Inc.; BVM Medical Limited; Erbe Elektromedizin GmbH; AtriCure Inc.; Theraclion; INTIO Inc.; BIOTRONIK SE & Co. KG; Olympus Corporation; Stryker Corporation; Merit Medical Systems Inc.; Insightec Ltd.; Terumo Corporation; Smith & Nephew plc; Monteris Medical Corporation; IceCure Medical Ltd.; Profound Medical Inc.; Alpinion Medical Systems Co. Ltd.; Sonacare Medical; Hologic Inc.; Endocare Inc.; Integra LifeSciences Corporation; Bovie Medical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Trends And Strategies

4. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Ablation Therapy Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Therapy Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM)

6. Tumor Ablation Therapy Devices Market Segmentation

  • 6.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • Other Technologies
  • 6.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical
  • Laparoscopic
  • Percutaneous
  • 6.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Clinics
  • Other End Users
  • 6.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monopolar RFA Devices
  • Bipolar RFA Devices
  • 6.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-frequency Microwave Devices
  • Low-frequency Microwave Devices
  • 6.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen-based Devices
  • Argon Gas-based Devices
  • 6.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NanoKnife Ablation Systems
  • High-voltage Pulse Generators
  • 6.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Ablation Devices
  • Ultrasound-guided High-intensity Focused Ultrasound (HIFU)
  • Chemical Ablation Techniques

7. Tumor Ablation Therapy Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Therapy Devices Market

  • 8.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Therapy Devices Market

  • 9.1. China Tumor Ablation Therapy Devices Market Overview
  • 9.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Therapy Devices Market

  • 10.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Therapy Devices Market

  • 11.1. Japan Tumor Ablation Therapy Devices Market Overview
  • 11.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Therapy Devices Market

  • 12.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Therapy Devices Market

  • 13.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Therapy Devices Market

  • 14.1. South Korea Tumor Ablation Therapy Devices Market Overview
  • 14.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Therapy Devices Market

  • 15.1. Western Europe Tumor Ablation Therapy Devices Market Overview
  • 15.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Therapy Devices Market

  • 16.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Therapy Devices Market

  • 17.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Therapy Devices Market

  • 18.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Therapy Devices Market

  • 19.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Therapy Devices Market

  • 20.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Therapy Devices Market

  • 21.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
  • 21.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Therapy Devices Market

  • 22.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Therapy Devices Market

  • 23.1. North America Tumor Ablation Therapy Devices Market Overview
  • 23.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Therapy Devices Market

  • 24.1. USA Tumor Ablation Therapy Devices Market Overview
  • 24.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Therapy Devices Market

  • 25.1. Canada Tumor Ablation Therapy Devices Market Overview
  • 25.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Therapy Devices Market

  • 26.1. South America Tumor Ablation Therapy Devices Market Overview
  • 26.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Therapy Devices Market

  • 27.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Therapy Devices Market

  • 28.1. Middle East Tumor Ablation Therapy Devices Market Overview
  • 28.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Therapy Devices Market

  • 29.1. Africa Tumor Ablation Therapy Devices Market Overview
  • 29.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Therapy Devices Market Competitive Landscape
  • 30.2. Tumor Ablation Therapy Devices Market Company Profiles
    • 30.2.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. EDAP TMS S.A.
  • 31.3. NeuWave Medical Inc.
  • 31.4. BVM Medical Limited
  • 31.5. Erbe Elektromedizin GmbH
  • 31.6. AtriCure Inc.
  • 31.7. Theraclion
  • 31.8. INTIO Inc.
  • 31.9. BIOTRONIK SE & Co. KG
  • 31.10. Olympus Corporation
  • 31.11. Stryker Corporation
  • 31.12. Merit Medical Systems Inc.
  • 31.13. Insightec Ltd.
  • 31.14. Terumo Corporation
  • 31.15. Smith & Nephew plc

32. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

34. Recent Developments In The Tumor Ablation Therapy Devices Market

35. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Therapy Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Therapy Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Therapy Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer